Key facts
- This page summarizes Gary B. Gordon's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 May 2026, 16:42.
Gary B. Gordon - 15 May 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)
- Reporting relationship
- Director
- Issuer ticker
- TLSI
- Reported as of
- 15 May 2026
- Net transaction value
- +$24,600
- SEC form
- 4
- Accepted by SEC
- 18 May 2026, 16:42:18 UTC
- Prior SEC filing
- 15 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mary Szela, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gary B. Gordon filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 18 May 2026.
Change
- Previous filing in this sequence was filed on 15 May 2026.
- Current net transaction value: +$24,600.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001811354
Primary reporting owner
Gordon Gary B.
- Relationship
- Director
- Address
- 6272 W. 91ST AVENUE, WESTMINSTER
- Signature
- /s/ Mary Szela, Attorney-in-Fact
- Signature date
- 18 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLSI
transaction
Common Stock
Purchase
- Transaction value
- $24,600
- Shares
- +10,000
- Change %
- +16%
- Price
- $2.46
- Shares after
- 72,510
- Date
- 15 May 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.